DOJ indicts Julian Ongpin for drug possession

Julian Ongpin—Photograph Courtesy of Philippine Nationwide Police-PRO1

MANILA, Philippines—The Division of Justice (DOJ) has indicted Julian Ongpin, son of businessman Roberto Ongpin, for possession of cocaine.

“The Panel of Prosecutors assigned to conduct the preliminary investigation of the criticism [filed by PNP San Juan La Union] resolved to indict respondent Julian Roberto Ongpin for possession of Harmful Medication (i.e. cocaine) beneath Part 11 of Republic Act No. 9165 or the Complete Harmful Medication Act of 2002,” learn the briefer from the DOJ.


The felony info might be filed earlier than the San Fernando, La Union Regional Trial Courtroom. Based mostly on the Data, the offense is non-bailable.

Ongpin is topic to a precautionary maintain departure order (PHDO) issued by the La Union Courtroom final Oct. 8, 2021.


INQUIRER.web has been making an attempt to get a response from Ongpin’s finish.

Ongpin has additionally been tagged as an individual of curiosity within the controversial demise of artist Breanna “Bree” Jonson, who was discovered unconscious on Sept. 18 inside the lavatory of the hostel room that they had rented within the browsing city of San Juan, La Union province.

He instructed police investigators that the painter had taken her personal life, a declare that Jonson’s household vigorously disputed.

Ongpin, 29, was launched from jail on Sept. 20 upon the native prosecutor’s order regardless of being charged with a nonbailable offense for possession of unlawful medicine.


DOJ takes over probe of Ongpin case

Guevarra vows thorough probe of artist’s death in La Union

Subscribe to our each day e-newsletter

Learn Subsequent


Do not miss out on the newest information and data.

Subscribe to INQUIRER PLUS to get entry to The Philippine Every day Inquirer & different 70+ titles, share as much as 5 devices, take heed to the information, obtain as early as 4am & share articles on social media. Name 896 6000.

For suggestions, complaints, or inquiries, contact us.